UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC ...

Medically reviewed by Peter Weiss, MD The menstrual cycle is a 21-35 day hormonal cycle during which estrogen and ...

UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...

Zinc is a mineral that’s responsible for everything from your immune system to wound healing. In fact, taking in enough zinc ...